DMK
TGTX icon

David M. Knott’s TG Therapeutics TGTX Stock Holding History

David M. Knott’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.65M Sell
49,592
-781
-2% -$24.2K 0.6% 44
2021
Q2 		$1.95M Sell
50,373
-1,600
-3% -$62.8K 0.69% 40
2021
Q1 		$2.5M Buy
51,973
+1,200
+2% +$57.7K 1.07% 26
2020
Q4 		$2.64M Hold
50,773
– – 1.2% 23
2020
Q3 		$1.36M Buy
50,773
+38,773
+323% +$892K 0.8% 30
2020
Q2 		$234K Buy
+12,000
New +$193K 0.13% 60

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David M. Knott's TGTX Position: Q3 2021 in Review

David M. Knott reduced its TG Therapeutics (TGTX) stake by 1.6% in Q3 2021, selling an estimated $24.2K and leaving 49,592 shares worth $1.65M. The position accounts for 0.6% of the portfolio, ranked #44.

David M. Knott first reported a position in TGTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $2.64M in Q4 2020. 222 funds tracked by Wall St. Rank hold TGTX as of Q3 2021.

  • David M. Knott held 49,592 shares of TG Therapeutics worth $1.65M as of Q3 2021.
  • David M. Knott sold 781 TG Therapeutics shares in Q3 2021, an estimated $24.2K.
  • TG Therapeutics made up 0.6% of David M. Knott's portfolio in Q3 2021, its #44 holding.
  • David M. Knott first reported a position in TG Therapeutics in Q2 2020 and has held it in 6 quarters since.
  • David M. Knott's TG Therapeutics position peaked at $2.64M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.